Democratic Republic of Congo vs Togo: Hepatitis B surface antigen (HBsAg) prevalence
Democratic Republic of Congo
1.4%
in 2024
Togo
1.4%
in 2024
Democratic Republic of Congo rank
19th
Togo rank
19th
Hepatitis B surface antigen (HBsAg) prevalence over time
- Democratic Republic of Congo
- Togo
How they compare
Democratic Republic of Congo currently reports 1.4% against 1.4% in Togo, a difference of 0.0%.
Across all 10 years both countries report, Togo has been ahead every year.
Democratic Republic of Congo ranks 19th and Togo ranks 19th of 194 countries.
Togo has averaged higher in every one of the 2 decades both report.
Head to head by decade
| Decade | Democratic Republic of Congo | Togo | Difference | Ahead |
|---|---|---|---|---|
| 2010s | 1.5% | 1.9% | 0.4% | Togo |
| 2020s | 1.4% | 1.5% | 0.1% | Togo |
Averages of every year both report within each decade.
Frequently asked questions
- Which has higher hepatitis b surface antigen (hbsag) prevalence, Democratic Republic of Congo or Togo?
- Democratic Republic of Congo, at 1.4% against 1.4% in Togo as of 2024.
- What is the difference in hepatitis b surface antigen (hbsag) prevalence between Democratic Republic of Congo and Togo?
- 0.0%, with Democratic Republic of Congo ahead.
- How many years of comparable data are there for Democratic Republic of Congo and Togo?
- 10 years are reported by both, from 2015 to 2024.
- How do Democratic Republic of Congo and Togo rank globally for hepatitis b surface antigen (hbsag) prevalence?
- Democratic Republic of Congo ranks 19th and Togo ranks 19th of 194 countries.
- Where does this data come from?
- World Health Organization, Global Health Observatory, published as Hepatitis B surface antigen (HBsAg) prevalence (%). Statizoid refreshes it automatically from the source and publishes the full history for both places.